Oragenics (OGEN) Catches Eye: Stock Rises 9.7% - Tale of the Tape

Oragenics Inc. (OGEN) was a big mover last session with its shares rising nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost nearly 25% in the past one-month time frame.

This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in a trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Oragenics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the biomedical industry may consider stocks like Myriad Genetics Inc. (MYGN), Gilead Sciences Inc. (GILD) and Illumina Inc. (ILMN). All three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

GILEAD SCIENCES (GILD): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

MYRIAD GENETICS (MYGN): Free Stock Analysis Report

ORAGENICS INC (OGEN): Get Free Report

To read this article on Zacks.com click here.

Zacks Investment Research